NPSA chief executives "on extended leave":
This article was originally published in Clinica
Executive Summary
The UK's National Patient Safety Agency (NPSA) has installed an acting chief executive, after putting Sue Osborn and Susan Williams, the agency's joint chief executives, on "a period of extended leave". The NPSA would not comment further on these developments, amid speculation that the move is in response to agency failures in relation to addressing adverse event rates and delays in the implementation of patient safety systems (see Clinica No 1214, pp 3 & 9). Bill Murray has 38 years' experience in the NHS, most recently as chief executive of South Tees Hospitals NHS Trust, for 12 years.
You may also be interested in...
Entries Begin To Roll In For 2024 Industry Awards
Entries have now begun rolling in for the Global Generics & Biosimilars Awards, which returns to Milan this October, Free to enter and attend, the ceremony recognizes the top achievements across the generics, biosimilars and value added medicines industries.
‘I Would Love To Have All The Biologic Assets’ – Formycon’s Glombitza Sets Out Portfolio Approach
In the second part of an exclusive interview, Formycon CEO Stefan Glombitza talks to Generics Bulletin about key regulatory developments in Europe and the US, the firm’s portfolio selection strategy, and upcoming milestones on the horizon.
First Off The Blocks, Fresenius Launches US Tocilizumab Biosimilar
Fresenius Kabi has kicked off competition to Genentech’s Actemra in the US, launching its Tyenne biosimilar version of tocilizumab.